Taylor & Francis Group
Browse
tveq_a_2349674_sm3071.docx (1.07 MB)

Sleep disturbance in clinical and preclinical scrapie-infected sheep measured by polysomnography

Download (1.07 MB)
journal contribution
posted on 2024-05-03, 06:00 authored by Diego Sola Fraca, Ernesto Sánchez Garrigós, Jorge de Francisco Moure, Belén Marín Gonzalez, Juan José Badiola Díez, Cristina Acín Tresaco

Neurodegenerative diseases are characterised by neuronal loss and abnormal deposition of pathological proteins in the nervous system. Among the most common neurodegenerative diseases are Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease and transmissible spongiform encephalopathies (TSEs). Sleep and circadian rhythm disturbances are one of the most common symptoms in patients with neurodegenerative diseases. Currently, one of the main objectives in the study of TSEs is to try to establish an early diagnosis, as clinical signs do not appear until the damage to the central nervous system is very advanced, which prevents any therapeutic approach. In this paper, we provide the first description of sleep disturbance caused by classical scrapie in clinical and preclinical sheep using polysomnography compared to healthy controls. Fifteen sheep classified into three groups, clinical, preclinical and negative control, were analysed. The results show a decrease in total sleep time as the disease progresses, with significant changes between control, clinical and pre-clinical animals. The results also show an increase in sleep fragmentation in clinical animals compared to preclinical and control animals. In addition, sheep with clinical scrapie show a total loss of Rapid Eye Movement sleep (REM) and alterations in Non Rapid Eyes Movement sleep (NREM) compared to control sheep, demonstrating more shallow sleep. Although further research is needed, these results suggest that prion diseases also produce sleep disturbances in animals and that polysomnography could be a diagnostic tool of interest in clinical and preclinical cases of prion diseases.

Funding

DS was supported by a doctoral grant from the Aragon Government. This research received no external funding neither to be published neither to be performed. This work was partially financed by reference group A19-20R funded by the Government of Aragón co-financed with FEDER 2014-2020 and the European Regional Development Fund (ERDF). This work was partially financed by reference group A05_20R Enfermedades Priónicas, Vectoriales y Zoonosis Emergentes.

History

Usage metrics

    Veterinary Quarterly

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC